Trademark Attorney / Law Firm
Chelsea Lockhart – Trademark Portfolio
Chelsea Lockhart specializes in Class 42 (Computer & Scientific) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 6 total filings concentrated in this category. The practice also covers Class 38 (Telecommunications) along with 4 other Nice Classification classes. Filing activity spans from 2015 to 2023. Currently, 6 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Chelsea Lockhart's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Chelsea Lockhart filed?
Chelsea Lockhart has filed 6 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 6 registered.
What trademark classes does Chelsea Lockhart specialize in?
Chelsea Lockhart has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 38 (Telecommunications), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
How long has Chelsea Lockhart been filing trademarks?
Chelsea Lockhart's trademark filing history with the USPTO spans from 2015 to 2023, covering 8 years of trademark practice. During this period, Chelsea Lockhart has handled 6 trademark applications.
What is Chelsea Lockhart's trademark registration success rate?
Chelsea Lockhart has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.